GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (STU:BKD) » Definitions » Cyclically Adjusted PS Ratio

Bruker (STU:BKD) Cyclically Adjusted PS Ratio : 3.97 (As of Sep. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bruker Cyclically Adjusted PS Ratio?

As of today (2024-09-21), Bruker's current share price is €60.70. Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was €15.29. Bruker's Cyclically Adjusted PS Ratio for today is 3.97.

The historical rank and industry rank for Bruker's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:BKD' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.94   Med: 3.6   Max: 7.22
Current: 4.18

During the past years, Bruker's highest Cyclically Adjusted PS Ratio was 7.22. The lowest was 1.94. And the median was 3.60.

STU:BKD's Cyclically Adjusted PS Ratio is ranked worse than
66.23% of 453 companies
in the Medical Devices & Instruments industry
Industry Median: 2.22 vs STU:BKD: 4.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bruker's adjusted revenue per share data for the three months ended in Jun. 2024 was €5.026. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €15.29 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bruker Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bruker's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Cyclically Adjusted PS Ratio Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 4.53 6.37 4.76 4.76

Bruker Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 4.07 4.76 5.92 3.95

Competitive Comparison of Bruker's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PS Ratio falls into.



Bruker Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bruker's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=60.70/15.29
=3.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Bruker's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=5.026/132.5538*132.5538
=5.026

Current CPI (Jun. 2024) = 132.5538.

Bruker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 1.921 100.428 2.536
201412 2.431 99.070 3.253
201503 1.925 99.621 2.561
201506 2.079 100.684 2.737
201509 2.092 100.392 2.762
201512 2.596 99.792 3.448
201603 2.052 100.470 2.707
201606 2.037 101.688 2.655
201609 2.173 101.861 2.828
201612 2.774 101.863 3.610
201703 2.242 102.862 2.889
201706 2.302 103.349 2.953
201709 2.303 104.136 2.931
201712 2.861 104.011 3.646
201803 2.230 105.290 2.807
201806 2.419 106.317 3.016
201809 2.541 106.507 3.162
201812 3.096 105.998 3.872
201903 2.586 107.251 3.196
201906 2.753 108.070 3.377
201909 3.041 108.329 3.721
201912 3.474 108.420 4.247
202003 2.469 108.902 3.005
202006 2.437 108.767 2.970
202009 2.814 109.815 3.397
202012 3.349 109.897 4.039
202103 3.041 111.754 3.607
202106 3.099 114.631 3.584
202109 3.387 115.734 3.879
202112 3.964 117.630 4.467
202203 3.568 121.301 3.899
202206 3.716 125.017 3.940
202209 4.342 125.227 4.596
202212 4.522 125.222 4.787
202303 4.337 127.348 4.514
202306 4.261 128.729 4.388
202309 4.725 129.860 4.823
202312 5.356 129.419 5.486
202403 4.551 131.776 4.578
202406 5.026 132.554 5.026

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bruker  (STU:BKD) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bruker Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bruker's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.